RSSS - NASDAQ

Research Solutions, Inc.

Research Solutions, Inc.

RSSS·NASDAQ

$2.21

+0.91%
TechnologySoftware - Application

Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$73.92M
EPS0.0412
P/E Ratio53.64
Earnings Date09/17/2026
46.12M
Assets
10%
3Y+171.0%
5Y+211.0%
10Y+273.0%
32.19M
Total Liabilities
7%
3Y+165.0%
5Y+223.0%
10Y+409.0%
13.93M
Total Equity
19%
3Y+185.0%
5Y+187.0%
10Y+131.0%
rsss

Research Solutions, Inc. Funding & Solvency Profile

RSSS · NASDAQ
Cash & Cash Equivalents12.23M
Net Receivables7.19M
Inventory0.00
Other Current Assets581.18K
Total Current Assets20 M
Property, Plant & Equipment60.77K
Goodwill & Intangible Assets26.06M
Long-Term Investments0.00
Other Non-Current Assets957.00
Total Non-Current Assets62 K
Total Assets
46.12M

Financial Health Analysis

Current Ratio

0.78x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

2.31x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-5509301

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

43% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Research Solutions, Inc. Balance Sheet

RSSS • NASDAQ

Research Solutions, Inc. Balance SheetJun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010Jun 2009Jun 2008Jun 2007
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents
12.2M
6.1M
13.5M
10.6M
11M
9.3M
5.4M
4.9M
5.8M
6.1M
1.4M
2.1M
1.7M
3.2M
2.9M
1.9M
1.9M
849.8K
382.6K
Short-Term Investments
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7M
2.6M
Cash & Short-Term Investments
12.2M
6.1M
13.5M
10.6M
11M
9.3M
5.4M
4.9M
5.8M
6.1M
1.4M
2.1M
1.7M
3.2M
2.9M
1.9M
1.9M
2.6M
3M
Net Receivables
7.2M
6.9M
6.2M
5.3M
4.7M
4.4M
4.5M
4.3M
5.5M
5.8M
4.9M
4M
5.1M
6.3M
7M
4.4M
3.5M
3.1M
1.3M
Accounts Receivables
7.2M
6.9M
6.2M
5.3M
4.7M
4.4M
4.5M
4.3M
5.5M
5.8M
4.9M
4M
5.1M
6.3M
6.7M
4.4M
3.5M
3.1M
1.3M
Other Receivables
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
356.5K
0.0
0.0
0.0
0.0
Inventory
0.0
0.0
1.2M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
192.2K
171.7K
363.6K
759.5K
6.6K
10.2K
16K
14.9K
Prepaids
0.0
1.1M
0.0
1.1M
904.9K
720.4K
323.6K
93.3K
566.3K
173.7K
442.8K
635.7K
351.9K
590.6K
1.5M
714.3K
218K
326.1K
312.5K
Other Current Assets
581.2K
643.6K
400.3K
0.0
270.3K
0.0
323.6K
0.0
0.0
0.0
0.0
1.3M
327.5K
0.0
18.3K
84.5K
37.9K
80.7K
27.8K
Total Current Assets
20M
14.7M
21.3M
17M
16.9M
14.7M
10.2M
9.6M
12M
12.2M
6.7M
8M
7.7M
10.4M
12.2M
7.1M
5.6M
6.1M
4.7M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)
60.8K
88K
70.2K
48K
20.8K
83.6K
229.1K
366.4K
503.7K
82.2K
83.2K
527.4K
831.2K
1.3M
1.7M
372.9K
340.8K
362.8K
253.2K
Goodwill
16.4M
16.3M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.6M
223.4K
223.4K
189.2K
199.2K
Intangible Assets
9.7M
10.8M
462.1K
0.0
0.0
0.0
0.0
0.0
41.9K
104.8K
0.0
55.2K
123.5K
65.5K
1.9M
674.8K
607.8K
611.7K
336.3K
Goodwill & Intangible Assets
26.1M
27.1M
462.1K
0.0
0.0
0.0
0.0
0.0
41.9K
104.8K
0.0
55.2K
123.5K
65.5K
3.5M
898.2K
831.2K
800.9K
535.5K
Other Non-Current Assets
957.0
981.0
1.1K
893.0
906.0
6.2K
14.4K
14.4K
14.5K
7.6K
9.5K
463.5K
286.1K
244.2K
308.7K
0.0
0.0
0.0
0.0
Total Non-Current Assets
26.1M
27.2M
533.3K
48.9K
21.7K
89.8K
243.5K
380.7K
560K
194.6K
92.7K
1M
1.2M
1.6M
5.4M
1.3M
1.2M
1.2M
788.7K
Total Assets
46.1M
41.9M
21.8M
17M
16.9M
14.8M
10.4M
10M
12.6M
12.4M
6.8M
9M
8.9M
12M
17.7M
8.4M
6.8M
7.3M
5.5M
LIABILITIES
CURRENT LIABILITIES
Total Payables
7.4M
8.8M
8.1M
6.6M
6.7M
6.3M
4.9M
-119.8K
-110.9K
5.7M
5.6M
5.7M
7.5M
9.6M
6.3M
4.9M
3M
2M
1.2M
Accounts Payable
7.4M
8.8M
8.1M
6.6M
6.7M
6.3M
4.9M
-119.8K
-110.9K
5.7M
5.6M
5.7M
7.5M
9.6M
6.3M
4.9M
3M
2M
1M
Other Payables
0.0
0.0
0.0
0.0
0.0
0.0
0.0
119.8K
110.9K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
3.7K
0.0
162.4K
Accrued Expenses
0.0
0.0
0.0
0.0
0.0
-3.6M
-2.4M
3M
5.1M
0.0
0.0
0.0
0.0
0.0
749K
97.8K
0.0
0.0
0.0
Short Term Debt
0.0
0.0
0.0
0.0
0.0
79.3K
129.2K
119.8K
110.9K
0.0
0.0
11.6K
276.8K
1.7M
2.2M
33.7K
17.9K
1.3M
6.2K
Capital Lease Obligations (Current)
0.0
0.0
0.0
0.0
0.0
79.3K
129.2K
119.8K
110.9K
0.0
0.0
0.0
221.5K
640.1K
664K
33.7K
17.9K
16.1K
0.0
Tax Payables
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
600.0
3.7K
0.0
0.0
Deferred Revenue
10.7M
9M
6.4M
5.5M
4.8M
3.5M
2.3M
1.7M
1.3M
639.8K
75.3K
158.4K
53.2K
68.9K
158.2K
600.0
3.7K
0.0
-6.2K
Other Current Liabilities
7.4M
0.0
0.0
0.0
0.0
-79.3K
-129.2K
4.7M
6.4M
0.0
0.0
3.4M
24.8K
-383.5K
-279.6K
-33.7K
98.9K
88.4K
233.9K
Total Current Liabilities
25.5M
17.9M
14.5M
12.1M
11.5M
10M
7.3M
6.5M
7.9M
6.3M
5.7M
9.3M
8.1M
11.6M
9.7M
5M
3.2M
3.4M
1.4M
NON-CURRENT LIABILITIES
Long Term Debt
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
504.1K
53.5K
110.1K
0.0
0.0
0.0
0.0
Deferred Tax Liabilities (Non-Current)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
350K
0.0
0.0
0.0
0.0
Other Non-Current Liabilities
6.7M
12.3M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-493K
0.0
359.3K
0.0
0.0
0.0
0.0
Total Non-Current Liabilities
6.7M
12.3M
0.0
0.0
0.0
0.0
79.3K
208.5K
328.3K
0.0
0.0
113.4K
504.1K
866.6K
2.1M
43.5K
43.6K
61.5K
0.0
Capital Lease Obligations
0.0
0.0
0.0
0.0
0.0
79.3K
208.5K
328.3K
439.2K
0.0
0.0
438.2K
714.5K
1.5M
1.9M
77.2K
61.5K
77.6K
0.0
Total Liabilities
32.2M
30.2M
14.5M
12.1M
11.5M
10M
7.4M
6.7M
8.2M
6.3M
5.7M
9.5M
8.6M
12.4M
11.8M
5.1M
3.2M
3.5M
1.4M
SHAREHOLDERS' EQUITY
Common Stock
32.5K
32.3K
29.5K
27.1K
26.5K
26K
24.4K
24K
23.9K
23.8K
18.2K
17.6K
17K
17.1K
16.8K
13K
13K
12.6K
12.5K
Additional Paid-In Capital
39.1M
38.1M
29.9M
28.1M
27M
26.1M
23.6M
22.9M
22.3M
21.6M
16.2M
15.4M
14.2M
13.7M
13.5M
5.5M
5.5M
4.6M
4.5M
Retained Earnings
-25M
-26.3M
-22.5M
-23.1M
-21.5M
-21.2M
-20.5M
-19.6M
-17.9M
-15.6M
-15.1M
-15.9M
-14M
-14.2M
-7.7M
-2.2M
-1.9M
-871K
-532.7K
Accumulated Other Comprehensive Income/Loss
-120.2K
-118.8K
-118.2K
-121.9K
-119.6K
-125K
-109.6K
-94.7K
-70.7K
-43.2K
-29.3K
16.1K
76K
60.7K
-11.6K
-317.6K
-188.3K
-89.7K
-15.3K
Total Stockholders' Equity
13.9M
11.7M
7.3M
4.9M
5.4M
4.9M
3M
3.3M
4.3M
6M
1.1M
-418.9K
314.2K
-434.6K
5.8M
3.3M
3.5M
3.8M
4M
Total Equity
13.9M
11.7M
7.3M
4.9M
5.4M
4.9M
3M
3.3M
4.3M
6M
1.1M
-418.9K
314.2K
-434.6K
5.8M
3.3M
3.6M
3.8M
4M
Minority Interest
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
34.9K
47.4K
50.1K
51.1K
SUMMARY
Total Liabilities & Equity
46.1M
41.9M
21.8M
17M
16.9M
14.8M
10.4M
10M
12.6M
12.4M
6.8M
9M
8.9M
12M
17.7M
8.4M
6.8M
7.3M
5.5M
Total Investments
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
1.7M
2.6M
Total Debt
0.0
0.0
0.0
0.0
0.0
79.3K
208.5K
328.3K
439.2K
0.0
0.0
449.8K
780.9K
2.6M
3.5M
77.2K
61.5K
1.4M
6.2K
Net Debt
-12.2M
-6.1M
-13.5M
-10.6M
-11M
-9.2M
-5.1M
-4.6M
-5.3M
-6.1M
-1.4M
-1.6M
-919.1K
-590.8K
676.9K
-1.8M
-1.8M
519.6K
-376.3K
Shares Outstanding
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800
32,821,800

SEC Filings

RSSS - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 15, 2026
March 31, 2026
2026
View Filing
8-K

8-K 2026

N/A

May 14, 2026
May 14, 2026
2026
View Filing
10-Q

10-Q 2025 Q4

Q4

February 13, 2026
December 31, 2025
2025
View Filing
8-K

8-K 2026

N/A

February 12, 2026
February 12, 2026
2026
View Filing
8-K

8-K 2025

N/A

December 11, 2025
December 10, 2025
2025
View Filing
10-Q

10-Q 2025 Q3

Q3

November 14, 2025
September 30, 2025
2025
View Filing
8-K

8-K 2025

N/A

November 13, 2025
November 12, 2025
2025
View Filing
8-K

8-K 2025

N/A

November 13, 2025
November 13, 2025
2025
View Filing
DEF 14A

DEF 14A 2025

N/A

September 24, 2025
November 12, 2025
2025
View Filing
10-K

10-K 2025 FY

FY

September 19, 2025
June 30, 2025
2025
View Filing
Showing 1 to 10 of 210 filings

Related Guides

Blog Categories

Continue your RSSS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.